TABLE 6D - INVALID PROCEDURE CODES
Procedure Code	Description	O.R.	MDC	MS-DRG
5A0512C*	Extracorporeal Supersaturated Oxygenation, Intermittent	N		
5A0522C*	Extracorporeal Supersaturated Oxygenation, Continuous	N		
D0Y0KZZ*	Laser Interstitial Thermal Therapy of Brain	Y	01	040, 041, 042
""				987, 988, 989
D0Y1KZZ*	Laser Interstitial Thermal Therapy of Brain Stem	Y	01	040, 041, 042
""				987, 988, 989
D0Y6KZZ*	Laser Interstitial Thermal Therapy of Spinal Cord	Y	01	040, 041, 042
""				987, 988, 989
D0Y7KZZ*	Laser Interstitial Thermal Therapy of Peripheral Nerve	Y	01	040, 041, 042
""				987, 988, 989
DBY0KZZ*	Laser Interstitial Thermal Therapy of Trachea	Y	04	166, 167, 168
""				987, 988, 989
DBY1KZZ*	Laser Interstitial Thermal Therapy of Bronchus	Y	04	166, 167, 168
""				987, 988, 989
DBY2KZZ*	Laser Interstitial Thermal Therapy of Lung	Y	04	166, 167, 168
""				987, 988, 989
DBY5KZZ*	Laser Interstitial Thermal Therapy of Pleura	Y	04	166, 167, 168
""				987, 988, 989
DBY6KZZ*	Laser Interstitial Thermal Therapy of Mediastinum	Y	04	166, 167, 168
""				987, 988, 989
DBY7KZZ*	Laser Interstitial Thermal Therapy of Chest Wall	Y	04	166, 167, 168
""				987, 988, 989
DBY8KZZ*	Laser Interstitial Thermal Therapy of Diaphragm	Y	04	166, 167, 168
""				987, 988, 989
DDY0KZZ*	Laser Interstitial Thermal Therapy of Esophagus	Y	06	356, 357, 358
""				987, 988, 989
DDY1KZZ*	Laser Interstitial Thermal Therapy of Stomach	Y	06	356, 357, 358
""				987, 988, 989
DDY2KZZ*	Laser Interstitial Thermal Therapy of Duodenum	Y	06	356, 357, 358
""				987, 988, 989
DDY3KZZ*	Laser Interstitial Thermal Therapy of Jejunum	Y	06	356, 357, 358
""				987, 988, 989
DDY4KZZ*	Laser Interstitial Thermal Therapy of Ileum	Y	06	356, 357, 358
""				987, 988, 989
DDY5KZZ*	Laser Interstitial Thermal Therapy of Colon	Y	06	356, 357, 358
""				987, 988, 989
DDY7KZZ*	Laser Interstitial Thermal Therapy of Rectum	Y	06	356, 357, 358
""				987, 988, 989
DDY8KZZ*	Laser Interstitial Thermal Therapy of Anus	Y	06	356, 357, 358
""				987, 988, 989
DFY0KZZ*	Laser Interstitial Thermal Therapy of Liver	Y	06	356, 357, 358
""			07	405, 406, 407
""				987, 988, 989
DFY1KZZ*	Laser Interstitial Thermal Therapy of Gallbladder	Y	07	423, 424, 425
""				987, 988, 989
DFY2KZZ*	Laser Interstitial Thermal Therapy of Bile Ducts	Y	07	423, 424, 425
""				987, 988, 989
DFY3KZZ*	Laser Interstitial Thermal Therapy of Pancreas	Y	07	423, 424, 425
""				987, 988, 989
DGY0KZZ*	Laser Interstitial Thermal Therapy of Pituitary Gland	Y	10	625, 626, 627
""				987, 988, 989
DGY1KZZ*	Laser Interstitial Thermal Therapy of Pineal Body	Y	10	625, 626, 627
""				987, 988, 989
DGY2KZZ*	Laser Interstitial Thermal Therapy of Adrenal Glands	Y	10	628, 629, 630
""				987, 988, 989
DGY4KZZ*	Laser Interstitial Thermal Therapy of Parathyroid Glands	Y	10	625, 626, 627
""				987, 988, 989
DGY5KZZ*	Laser Interstitial Thermal Therapy of Thyroid	Y	10	625, 626, 627
""				987, 988, 989
DMY0KZZ*	Laser Interstitial Thermal Therapy of Left Breast	Y	09	584, 585
""				987, 988, 989
DMY1KZZ*	Laser Interstitial Thermal Therapy of Right Breast	Y	09	584, 585
""				987, 988, 989
DVY0KZZ*	Laser Interstitial Thermal Therapy of Prostate	Y	12	715, 716, 717, 718
""				987, 988, 989
X2RF032*	Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Open Approach, New Technology Group 2	Y	05	216, 217, 218, 219, 220, 221
""				981, 982, 983
X2RF332*	Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Approach, New Technology Group 2	Y	05	266, 267
""				981, 982, 983
X2RF432*	Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Endoscopic Approach, New Technology Group 2	Y	05	216, 217, 218, 219, 220, 221
""				981, 982, 983
XHRPXL2*	Replacement of Skin using Porcine Liver Derived Skin Substitute, External Approach, New Technology Group 2	Y	01	040, 041, 042
""			03	143, 144, 145
""			05	264
""			08	463, 464, 465
""			09	573, 574, 575, 576, 577, 578
""			10	622, 623, 624
""			13	746, 747
""			21	904, 905
""			22	927, 928, 929
""			24	957, 958, 959
""				981, 982, 983
XK02303*	Introduction of Concentrated Bone Marrow Aspirate into Muscle, Percutaneous Approach, New Technology Group 3	N		
XRG0092*	Fusion of Occipital-cervical Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	471, 472, 473
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG00F3*	Fusion of Occipital-cervical Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	471, 472, 473
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG1092*	Fusion of Cervical Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 471, 472, 473
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG10F3*	Fusion of Cervical Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 471, 472, 473
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG2092*	Fusion of 2 or more Cervical Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 471, 472, 473
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG20F3*	Fusion of 2 or more Cervical Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 471, 472, 473
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG4092*	Fusion of Cervicothoracic Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 471, 472, 473
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG40F3*	Fusion of Cervicothoracic Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 471, 472, 473
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG6092*	Fusion of Thoracic Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG60F3*	Fusion of Thoracic Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG7092*	Fusion of 2 to 7 Thoracic Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG70F3*	Fusion of 2 to 7 Thoracic Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG8092*	Fusion of 8 or more Thoracic Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRG80F3*	Fusion of 8 or more Thoracic Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGA092*	Fusion of Thoracolumbar Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGA0F3*	Fusion of Thoracolumbar Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGB092*	Fusion of Lumbar Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGB0F3*	Fusion of Lumbar Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGC092*	Fusion of 2 or more Lumbar Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGC0F3*	Fusion of 2 or more Lumbar Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGD092*	Fusion of Lumbosacral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGD0F3*	Fusion of Lumbosacral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3	Y	01	028, 029, 030
""			08	453, 454, 455, 456, 457, 458, 459, 460
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XW03392*	Introduction of Defibrotide Sodium Anticoagulant into Peripheral Vein, Percutaneous Approach, New Technology Group 2	N		
XW033A3*	Introduction of Bezlotoxumab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 3	N		
XW04392*	Introduction of Defibrotide Sodium Anticoagulant into Central Vein, Percutaneous Approach, New Technology Group 2	N		
XW043A3*	Introduction of Bezlotoxumab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 3	N		

	Notes:
	(*)-These codes were discussed at the March 8, 2022 - March 9, 2022 ICD-10 Coordination and Maintenance Committee meeting and were not finalized in time to include in the proposed rule. They will be implemented on October 1, 2022.
